ESC 365 - From early development to confirmation in humans: the long road to drug development

Open Access

From early development to confirmation in humans: the long road to drug development

Session: Understanding the cardiovascular effects of SGLT2 inhibitors

Topic: Basic Science

Speaker: Professor S. Solomon (Boston, US)

Event: HFA Winter Research Meeting on Translational Heart Failure 2023

Seminar Presentation

About the speaker

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)

68 presentations

22 followers

3 more presentations in this session

It is a renal effect

Speaker: Professor G. Savarese (Stockholm, SE)

It is a metabolic effect

Speaker: Professor C. Maack (Wuerzburg, DE)

It is due to NHE blockade at the cardiomyocyte

Speaker: Doctor O. Iborra Egea (Badalona, ES)

Access the full session

Understanding the cardiovascular effects of SGLT2 inhibitors

Speakers: Professor S. Solomon, Professor G. Savarese, Professor C. Maack, Doctor O. Iborra Egea

About the event

HFA Winter Research Meeting on Translational Heart Failure 2023

15 March - 18 March 2023

Seminar

ESC 365 is supported by